These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 5471131)

  • 21. [Intolerance of medicinal preparations at different stages of the treatment of tuberculosis].
    Rudoĭ NM; Simonian LK; Repina LO
    Klin Med (Mosk); 1973 Mar; 51(3):80-3. PubMed ID: 4755486
    [No Abstract]   [Full Text] [Related]  

  • 22. [Tuberculostatic preparations of the 2d series in the treatment of chronic forms of pulmonary tuberculosis in children and adolescents].
    Kshanovskiĭ SA; Rushak VA
    Probl Tuberk; 1972; 50(6):38-41. PubMed ID: 4538124
    [No Abstract]   [Full Text] [Related]  

  • 23. [Anaphylactic shock caused by antitubercular drugs in a case of tuberculosis with primary resistance to 4 drugs].
    Rózewska M; Graczyk J
    Gruzlica; 1970 Mar; 38(3):257-60. PubMed ID: 5527050
    [No Abstract]   [Full Text] [Related]  

  • 24. [Drug allergy in chemotherapy of pulmonary tuberculosis].
    Tuganova VE
    Klin Med (Mosk); 1972 Jul; 50(7):108-11. PubMed ID: 5052620
    [No Abstract]   [Full Text] [Related]  

  • 25. [Intolerance to antibacterial preparations of the first series in a child with tuberculous bronchoadenitis].
    Cherednikova GV
    Probl Tuberk; 1969; 47(4):79-81. PubMed ID: 5308600
    [No Abstract]   [Full Text] [Related]  

  • 26. [Dispensary registry of patients with pulmonary tuberculosis at the present stage of long-term treatment with tuberculostatic preparations].
    Oĭfebakh MI; Levin VR; Modelevskiĭ BSh
    Probl Tuberk; 1969; 47(2):4-8. PubMed ID: 5377329
    [No Abstract]   [Full Text] [Related]  

  • 27. [Negativation of developing pulmonary tuberculosis under tuberculostatic therapy].
    Cosemans J; Gyselen A; Verbist L; Doms F
    Acta Tuberc Pneumol Belg; 1968; 59(1):337-49. PubMed ID: 5739133
    [No Abstract]   [Full Text] [Related]  

  • 28. [The efficacy of the intermittent method in the use of tuberculostatic preparations of the 1st and 2nd series in the treatment of patients with destructive forms of pulmonary tuberculosis].
    Navrotskiĭ VV; Pertsovskiĭ AI; Belogurova VP
    Probl Tuberk; 1968; 46(11):39-43. PubMed ID: 5711714
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical evaluation of side effects during chemotherapy of tuberculosis].
    Eĭnis VL; Tuganova VE
    Probl Tuberk; 1970; 48(6):18-22. PubMed ID: 5447927
    [No Abstract]   [Full Text] [Related]  

  • 30. [Follow-up studies on patients with chronic pulmonary tuberculosis treated with secondary tuberculostatic agents].
    Böszörményi M; Faust I; Barát I; Schweiger O
    Probl Tuberk; 1965; 43(8):39-45. PubMed ID: 5869918
    [No Abstract]   [Full Text] [Related]  

  • 31. [Certain pharmacotherapeutic properties of heparin and its importance in complex treatment of tuberculosis (literature review)].
    Puzik VI; Makinskiĭ AI
    Probl Tuberk; 1974; (11):14-22. PubMed ID: 4155799
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antibacterial drugs and their tolerance in children with tuberculosis].
    Naubet'iarova AI; Alibakieva GM; Kim LI; Balgabekova BB
    Probl Tuberk; 1988; (12):21-3. PubMed ID: 3266669
    [No Abstract]   [Full Text] [Related]  

  • 33. [Tuberculostatic preparation tolerance in elderly patients with a chronic course of pulmonary tubercuosis and concomitant diseases].
    Utkin VV; Mikheeva LP; Poleshchuk AK; Krylova NP
    Probl Tuberk; 1980 Sep; (9):42-5. PubMed ID: 7422656
    [No Abstract]   [Full Text] [Related]  

  • 34. [Characteristics of the course of pulmonary tuberculosis in patients with severe forms of drug allergy].
    Dobychina AI
    Probl Tuberk; 1966; 44(5):40-3. PubMed ID: 5993149
    [No Abstract]   [Full Text] [Related]  

  • 35. [Lipid peroxidation indices of the blood in children with tuberculosis and drug allergy].
    Kazakov KS; Piataeva EV; Sidorova LL
    Probl Tuberk; 1985; (10):41-5. PubMed ID: 3877929
    [No Abstract]   [Full Text] [Related]  

  • 36. [The use of prednisolone in patients with active pulmonary tuberculosis].
    Sergeev IS; Pervova TN; Starostenko EV; Ignatova AV; Noskova GP
    Probl Tuberk; 1969; 47(2):40-5. PubMed ID: 5380562
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinico-biomedical characteristics in manifestations of drug intolerance in patients with pulmonary tuberculosis].
    Sergeev IS; Ignatova AV
    Sov Med; 1973 Jul; 36(7):35-9. PubMed ID: 4776705
    [No Abstract]   [Full Text] [Related]  

  • 38. [Agglomeration test in complications of chemotherapy of tuberculosis].
    Tuganova VE; Mats AN; Iusinova IP
    Klin Med (Mosk); 1975 Apr; 53(4):111-4. PubMed ID: 1152357
    [No Abstract]   [Full Text] [Related]  

  • 39. [Importance of tuberculin tests in the evaluation of the effectiveness of treatment of destructive pulmonary tuberculosis].
    Slonchak AT
    Probl Tuberk; 1974; (1):26-9. PubMed ID: 4457885
    [No Abstract]   [Full Text] [Related]  

  • 40. [The early diagnosis of drug allergy by biophysical methods].
    Shchutskaia EI; Kolpakova TA; Priakhina VN
    Probl Tuberk; 1992; (11-12):62-3. PubMed ID: 1289895
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.